Southbound funds net buy HK$2.9bn, extending 14-day inflow streak
Editorial responsibility
- No named human review is recorded for this page.
- Source reporting is collected, normalized, translated or condensed automatically when needed.
- Automatically published source-backed update
Southbound funds through the Stock Connect program recorded a net purchase of approximately HK$2.9 billion on September 24, according to data from Cailianshe. The Tracker Fund of Hong Kong (盈富基金) and Tencent Holdings were the top beneficiaries, receiving net inflows of about HK$633 million and HK$630 million, respectively. In contrast, Genscript Biotech Corporation saw net selling of HK$279 million. The report notes that southbound funds have maintained a net inflow streak for 14 consecutive trading days, accumulating total net purchases of approximately HK$55.227 billion during this period. The data reflects continued capital flow from mainland China into Hong Kong-listed assets.
Source report
September 24 (Caixin) — Southbound capital recorded a net purchase of approximately HK$2.9 billion today.
- Top buys: Tracker Fund of Hong Kong (盈富基金) and Tencent Holdings (腾讯控股) saw net purchases of around HK$633 million and HK$630 million, respectively.
- Top sell: Genscript Biotech (金斯瑞生物科技) recorded a net sell-off of HK$279 million.
Note: Southbound capital has now recorded net inflows for 14 consecutive trading days, with total net purchases reaching approximately HK$55.227 billion.
Source
财联社Eastern
Part of this Story
Southbound Capital Net Buys 12.69 Billion HKD, Tracker Fund Gets 2.68 Billion